🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Vaccines are critical for the protection of patients from infection - it was an honor to write this piece discussing the challenges and data needs for use in immunocompromised patients. academic.oup.com/jid/article/23…

פריצת דרך בטיפול בסוכרת! מחקר חדש בבילינסון והשרון מגלה כי שילוב של מטפורמין עם תרופות ממשפחת SGLT2 מפחית ב-35% את הסיכון לאי-ספיקת כליות וב-26% את הסיכון לתמותה. המחקר, שנעשה על יותר מ-45,000 חולי סוכרת, מראה שהשילוב לא רק מאזן את הסוכר, אלא גם מגן על הכליות והלב. פרופ' רוזן

Excited to share the fourth version of the international consensus guidelines on CMV management after a solid organ transplant, on behalf of all 50 contributors and TTS.bsky.social journals.lww.com/transplantjour…

I was delighted to share the stage with Maheen Abidi in meet the expert session at #ESCMIDGlobal2025 🇦🇹. We discussed the growing importance of much needed research on aging syndromes and infections in organ transplant recipients.

Rare but significant complication of intensive therapy for acute #leukemia. Epiglottitis in patients treated for acute leukemia – Case series and systematic review of the literature karger.com/aha/article/do…

The 2026 CDC yellow book on travel medicine is live at this link for those who are interested books.google.com/books/about/CD… David O. Freedman

Malignancy risk is higher among SOT recipients. 4 non-hepatitis viruses recognized as oncogenic in SOT recipients (EBV,HHV8, HPV, Merkel cell polyomavirus). This review discusses the prevention of #EBV & #HHV8 in SOT 👇 pmc.ncbi.nlm.nih.gov/articles/PMC... #TxID #IDxposts #IDTwitter

Population-based study of Candidemia over 20-years: resistance, recurrence and mortality 🇦🇺🧫📈. Made available just in time for its oral presentation at ISHAM #ISHAM2025 | journalofinfection.com/article/S0163-…

Pts with heme malignancies are at ⬆️ risk for severe COVID19. Vaccines are key preventive strategy, but the response is variable. This review is based on the authors expert opinions informed by their experiences & literature search Shmuel Shoham Daniele Focosi, MD PhD MSc doi.org/10.1080/174740…

Interested in learning more about resistant refractory CMV after organ transplantation? Join us this Wednesday 6 PM ET. Open for audience questions at the end! ⁦Emily Blumberg⁩ pathlms.com/catalyst/webin… pathlms.com/catalyst/webin…

Your work needs revision Reviewer#1: please use the term X instead of Y. Reviewer#2: please use the term Y instead of X

Do you remember when you joined X? I do! #MyXAnniversary